白蛋白治疗急性重型脑梗死临床疗效观察

目的:观察分析白蛋白治疗急性重型脑梗死的临床疗效及安全性。方法:78例急性重型脑梗死患者分为两组,两组均采用常规治疗。治疗组加用10%白蛋白100mL静脉滴注1次/d,连续用7d,14d为一疗程。比较治疗前后两组神经功能缺损程度评分变化。结果:治疗后治疗组总有效率及神经功能缺损评分改善情况均优于对照组,有显著统计学意义(P<0.05),治疗过程中无不良反应发生。结论:白蛋白治疗急性重型脑梗死临床疗效确切、安全。

Clinical study on Albumin Treating Acute Severe Cerebral Infarction

Abstract: Objective: To observe the clinical effect and safety of Albumin in treatment of acute severe cerebral infarction. Methods: 78 patients with acute severe cerebral infarction were randomly divided into 2 groups, 38 cases in the control group were given routine therapy. 40 cases in the treating group were given routine therapy plus 10% Albumin 100ml ivgtt once a day for 7 days. 14 days served as a treatment course; comparative study of the change of neurofunction was made before and after treatment. Results: After treatment the total effective rate in the treating group was higher than that of the control group（P<0.05）; the improvement degree of neurofunctional deficits in the treating group was superior to that of the control group（P<0.05）. Conclusions: Albumin is an effective and safe medicine for treatment of acute severe cerebral infarction.